Condition
Anembryonic Pregnancy
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
67%
2 of 3 completed with results
Key Signals
2 with results75% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 2 (1)
P 4 (1)
Trial Status
Completed3
Terminated1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05198050Not ApplicableCompletedPrimary
Letrozole in Induction of Abortion of Anembryonic Pregnancy
NCT05216952Phase 2Completed
Ulipristal Acetate for Use in Early Pregnancy Loss
NCT00177372Phase 4CompletedPrimary
Mifepristone and Misoprostol for Fetal Demise
NCT00468299Not ApplicableTerminated
MiMi: A Randomized Trial of Mifepristone and Misoprostol for Treatment of Early Pregnancy Failure
Showing all 4 trials